Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Development and internal validation of a machine learning model for predicting acute chemotherapy-induced nausea and vomiting after intra-arterial interventional therapy in patients with liver cancer.

Created on 15 Nov 2026

Authors

Yan Lu, Ruishuang Zheng, Haipeng Yu, Xueling Yang, Yanan Liu, Yongjian Wang, Dongjun Liu

Published in

Asia-Pacific journal of oncology nursing. Volume 13. Pages 101040. Epub Oct 03, 2026.

Abstract

To develop and internally validate an interpretable machine learning model for predicting acute chemotherapy-induced nausea and vomiting (ACINV) after intra-arterial interventional therapy (IAIT) in patients with primary liver cancer.
This retrospective cohort included 1062 patients who underwent IAIT in China. ACINV was defined as Common Terminology Criteria for Adverse Events (CTCAE) grade ≥ 2 nausea or vomiting within 24 hours. Patients were allocated to a training set (n = 638) and a held-out internal validation set (n = 424). Seven algorithms were compared using nested stratified five-fold cross-validation. Outer folds generated out-of-fold (OOF) predictions, whereas inner folds supported tuning and threshold selection. Imputation, encoding, standardization, and least absolute shrinkage and selection operator (LASSO) selection were fitted only to training observations in each partition. Preprocessing was re-estimated within folds used for LASSO penalty selection. SMOTE was applied only within model-fitting partitions after predictor selection. Algorithms were ranked by pooled OOF area under the curve (AUC), with the Brier score resolving ties. The selected pipeline was refitted on the complete training set and evaluated in internal validation.
ACINV occurred in 380 patients (35.8%). The final refit retained 11 predictors. Random forest achieved the highest pooled OOF AUC (0.941; 95% CI, 0.923-0.958) and a Brier score of 0.092. In internal validation, its AUC was 0.962 (95% CI, 0.946-0.978), Brier score was 0.073, calibration intercept was -0.090, and calibration slope was 1.056. SHAP analysis supported model interpretation, and the locked model was incorporated into a prototype calculator.
The model showed promising internal performance. External validation and prospective impact evaluation are required before clinical implementation.
This study was registered in Chinese Clinical Trial Registry (ChiCTR-2500110585).

PMID:
43034587
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement